Corrigendum: Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system (Nature Communications (2015) 6 (6761) DOI: 10.1038/ncomms7761);Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system

Nature Communications

Volumn 6, Issue , 2015, Pages

  Baxter, Paul S ^a   Bell, Karen F S ^a   Hasel, Philip ^a   Kaindl, Angela M ^b   Fricker, Michael ^c   Thomson, Derek ^a   Cregan, Sean P ^d   Gillingwater, Thomas H ^a   Hardingham, Giles E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ADENOSINE TRIPHOSPHATE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE OXYGEN METABOLITE; AMINO ACID RECEPTOR BLOCKING AGENT; APOPTOSIS REGULATORY PROTEIN; DIZOCILPINE MALEATE; GLUTATHIONE TRANSFERASE; NFE2L2 PROTEIN, RAT; PUMA PROTEIN, MOUSE; TRANSCRIPTION FACTOR NRF2; TUMOR SUPPRESSOR PROTEIN;

ANTIOXIDANT; APOPTOSIS; GENE EXPRESSION; NERVOUS SYSTEM DISORDER; NEUROLOGY; REDOX CONDITIONS;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; BIOSYNTHESIS; CONTROLLED STUDY; DETOXIFICATION; ELECTROENCEPHALOGRAM; GENE EXPRESSION; NEGATIVE FEEDBACK; NERVE CELL NETWORK; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PEROXIDATION; PROMOTER REGION; PROTEIN DEPLETION; RAT; SYNAPSE; TRANSCRIPTION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ELECTRICAL SYNAPSE; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; NERVE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; DIZOCILPINE MALEATE; ELECTRICAL SYNAPSES; EXCITATORY AMINO ACID ANTAGONISTS; FRONTAL LOBE; GENE EXPRESSION REGULATION; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MICE; MICE, KNOCKOUT; NEURONS; NF-E2-RELATED FACTOR 2; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84927649811     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms16158     Document Type: Erratum

References (70)

1. Dringen, R. & Hirrlinger, J. Glutathione pathways in the brain. Biol. Chem. 384, 505-516 (2003).
2. Fernandez-Fernandez, S., Almeida, A. & Bolanos, J. P. Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem. J. 443, 3-11 (2012).
3. Johnson, W. M., Wilson-Delfosse, A. L. & Mieyal, J. J. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients 4, 1399-1440 (2012).
4. Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P. & Cuenod, M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr. Opin. Neurobiol. 19, 220-230 (2009).
5. Kulak, A. et al. Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models. Antioxid. Redox Signal. 18, 1428-1443 (2013).
6. Ghanizadeh, A. et al. Glutathione-related factors and oxidative stress in autism, a review. Curr. Med. Chem. 19, 4000-4005 (2012).
7. Frustaci, A. et al. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic. Biol. Med. 52, 2128-2141 (2012).
8. Steullet, P. et al. Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J. Neurosci. 30, 2547-2558 (2010).
9. Gysin, R. et al. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc. Natl Acad. Sci. USA 104, 16621-16626 (2007).
10. Steullet, P., Neijt, H. C., Cuenod, M. & Do, K. Q. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience 137, 807-819 (2006).
11. Lipton, S. A. et al. Cysteine regulation of protein function - as exemplified by NMDA-receptor modulation. Trends Neurosci. 25, 474-480 (2002).
12. Carlson, G. C. Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders. Pharmacol. Biochem. Behav. 100, 850-854 (2012).
13. Fountoulakis, K. N. The possible involvement of NMDA glutamate receptor in the etiopathogenesis of bipolar disorder. Curr. Pharm. Des. 18, 1605-1608 (2012).
14. Kantrowitz, J. T. & Javitt, D. C. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res. Bull. 83, 108-121 (2010).
15. Schwartz, T. L., Sachdeva, S. & Stahl, S. M. Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia. Curr. Pharm. Des. 18, 1580-1592 (2012).
16. Olney, J. W. et al. The enigma of fetal alcohol neurotoxicity. Ann. Med. 34, 109-119 (2002).
17. Chatterjee, S., Noack, H., Possel, H., Keilhoff, G. & Wolf, G. Glutathione levels in primary glial cultures: monochlorobimane provides evidence of cell type-specific distribution. Glia 27, 152-161 (1999).
18. Sun, X. et al. Two-photon imaging of glutathione levels in intact brain indicates enhanced redox buffering in developing neurons and cells at the cerebrospinal fluid and blood-brain interface. J. Biol. Chem. 281, 17420-17431 (2006).
19. Steckley, D. et al. Puma is a dominant regulator of oxidative stress induced Bax activation and neuronal apoptosis. J. Neurosci. 27, 12989-12999 (2007).
20. Harris, J. J., Jolivet, R. & Attwell, D. Synaptic energy use and supply. Neuron 75, 762-777 (2012).
21. Hardingham, G. E., Arnold, F. J. & Bading, H. Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat. Neurosci. 4, 261-267 (2001).
22. Papadia, S., Stevenson, P., Hardingham, N. R., Bading, H. & Hardingham, G. E. Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J. Neurosci. 25, 4279-4287 (2005).
23. Marvin, J. S. et al. An optimized fluorescent probe for visualizing glutamate neurotransmission. Nat. Methods 10, 162-170 (2013).
24. Hongpaisan, J., Winters, C. A. & Andrews, S. B. Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. J. Neurosci. 24, 10878-10887 (2004).
25. Brennan, A. M. et al. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci. 12, 857-863 (2009).
26. Gutscher, M. et al. Real-time imaging of the intracellular glutathione redox potential. Nat. Methods 5, 553-559 (2008).
27. Papadia, S. et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat. Neurosci. 11, 476-487 (2008).
28. Griffith, O. W. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med. 27, 922-935 (1999).
29. Bell, K. F. et al. Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc. Natl Acad. Sci. USA 108, E1-E2 author reply E3-4 (2011).
30. Li, M., Chiu, J. F., Kelsen, A., Lu, S. C. & Fukagawa, N. K. Identification and characterization of an Nrf2-mediated ARE upstream of the rat glutamate cysteine ligase catalytic subunit gene (GCLC). J. Cell. Biochem. 107, 944-954 (2009).
31. Vargas, M. R. & Johnson, J. A. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev. Mol. Med. 11, e17 (2009).
32. Hayes, J. D., McMahon, M., Chowdhry, S. & Dinkova-Kostova, A. T. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid. Redox Signal. 13, 1713-1748 (2010).
33. Gupta, K., Chandran, S. & Hardingham, G. E. Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration. Br. J. Clin. Pharmacol. 75, 907-918 (2012).
34. Shih, A. Y. et al. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 23, 3394-3406 (2003).
35. Diaz-Hernandez, J. I., Almeida, A., Delgado-Esteban, M., Fernandez, E. & Bolanos, J. P. Knockdown of glutamate-cysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons. J. Biol. Chem. 280, 38992-39001 (2005).
36. Yates, M. S. et al. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol. Cancer Ther. 6, 154-162 (2007).
37. Gupta, K. et al. Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ. 19, 779-787 (2012).
38. Ikonomidou, C. Triggers of apoptosis in the immature brain. Brain. Dev. 31, 488-492 (2009).
39. Quintana-Cabrera, R. et al. gamma-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor. Nat. Commun. 3, 718 (2012).
40. Harris, L. W., Sharp, T., Gartlon, J., Jones, D. N. & Harrison, P. J. Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur. J. Neurosci. 18, 1706-1710 (2003).
41. Fredriksson, A., Archer, T., Alm, H., Gordh, T. & Eriksson, P. Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav. Brain Res. 153, 367-376 (2004).
42. Drake, J., Kanski, J., Varadarajan, S., Tsoras, M. & Butterfield, D. A. Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J. Neurosci. Res. 68, 776-784 (2002).
43. Hardingham, G. E. & Lipton, S. A. Regulation of neuronal oxidative and nitrosative stress by endogenous protective pathways and disease processes. Antioxid. Redox Signal. 14, 1421-1424 (2011).
44. Bell, K. F. & Hardingham, G. E. CNS peroxiredoxins and their regulation in health and disease. Antioxid. Redox Signal. 14, 1467-1477 (2011).
45. Hardingham, G. E. & Bading, H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682-696 (2010).
46. Bell, K. F. & Hardingham, G. E. The influence of synaptic activity on neuronal health. Curr. Opin. Neurobiol. 21, 299-305 (2011).
47. Wahl, A. S. et al. Hypoxic/ischemic conditions induce expression of the putative pro-death gene Clca1 via activation of extrasynaptic N-methyl-D-aspartate receptors. Neuroscience 158, 344-352 (2009).
48. Lipton, S. A. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. Drug Discov. 5, 160-170 (2006).
49. Xia, P., Chen, H. S., Zhang, D. & Lipton, S. A. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J. Neurosci. 30, 11246-11250 (2010).
50. Parsons, M. P. & Raymond, L. A. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 82, 279-293 (2014).
51. Cabungcal, J. H., Steullet, P., Kraftsik, R., Cuenod, M. & Do, K. Q. Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine. Biol. Psychiatry 73, 574-582 (2013).
52. Porteous, D. J., Millar, J. K., Brandon, N. J. & Sawa, A. DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol. Med. 17, 699-706 (2011).
53. Ma, T. M. et al. Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion. Mol. Psychiatry 18, 557-567 (2013).
54. Wei, J. et al. Regulation of N-Methyl-D-aspartate receptors by disrupted-in-schizophrenia-1. Biol. Psychiatry 75, 414-424 (2013).
55. Monin, A. et al. Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients. Mol. Psychiatry. doi:10.1038/mp.201488 (2014).
56. Cabungcal, J. H. et al. Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia. Neuron 83, 1073-1084 (2014).
57. Janaky, R. et al. Glutathione and signal transduction in the mammalian CNS. J. Neurochem. 73, 889-902 (1999).
58. Radonjic, N. V. et al. Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration. Neuropharmacology 58, 739-745 (2010).
59. da Silva, F. C. et al. Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice. Brain Res. Bull. 83, 9-15 (2010).
60. Qiu, J. et al. Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals. Nat. Commun. 4, 2034 (2013).
61. Puddifoot, C. et al. PGC-1alpha negatively regulates extrasynaptic NMDAR activity and excitotoxicity. J. Neurosci. 32, 6995-7000 (2012).
62. Villunger, A. et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302, 1036-1038 (2003).
63. Soriano, F. X. et al. Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione. J. Neurochem. 107, 533-543 (2008).
64. Spain, A. et al. Mild fluid percussion injury in mice produces evolving selective axonal pathology and cognitive deficits relevant to human brain injury. J. Neurotrauma 27, 1429-1438 (2010).
65. Griffith, O. W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212 (1980).
66. Kamencic, H., Lyon, A., Paterson, P. G. & Juurlink, B. H. Monochlorobimane fluorometric method to measure tissue glutathione. Anal. Biochem. 286, 35-37 (2000).
67. White, C. C., Viernes, H., Krejsa, C. M., Botta, D. & Kavanagh, T. J. Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Anal. Biochem. 318, 175-180 (2003).
68. Tate, S. S. & Meister, A. Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase. Proc. Natl Acad. Sci. USA 75, 4806-4809 (1978).
69. Orwar, O., Fishman, H. A., Ziv, N. E., Scheller, R. H. & Zare, R. N. Use of 2,3-naphthalenedicarboxaldehyde derivatization for single-cell analysis of glutathione by capillary electrophoresis and histochemical localization by fluorescence microscopy. Anal. Chem. 67, 4261-4268 (1995).
70. Flohe, L. & Gunzler, W. A. Assays of glutathione peroxidase. Methods Enzymol. 105, 114-121 (1984).